These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3234250)

  • 1. Disposition of cefonicid in orthopedic surgery patients.
    Ackerman BH; Trang JM; Nelson CL; Pearce CE; Manning JT; Harrison BH
    Drug Intell Clin Pharm; 1988 Nov; 22(11):864-8. PubMed ID: 3234250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
    Heim-Duthoy KL; Peltier GL; Guay DR; Matzke GR
    Antimicrob Agents Chemother; 1988 Apr; 32(4):485-7. PubMed ID: 3377460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue penetration and half-life of cefonicid.
    Nightingale CH; Quintiliani R; Dudley MN; Gough P; Hickingbotham M; Jordan NS; Rose D; Toscani M
    Rev Infect Dis; 1984; 6 Suppl 4():S821-8. PubMed ID: 6522924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
    Dudley MN; Shyu WC; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M; Savio S; Concia E
    Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of age and renal function on cefonicid pharmacokinetics.
    Trang JM; Monson TP; Ackerman BH; Underwood FL; Manning JT; Kearns GL
    Antimicrob Agents Chemother; 1989 Feb; 33(2):142-6. PubMed ID: 2719458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of intramuscular cefonicid in elderly patients.
    Karki SD; Bentley DW; Luzier A; Taylor C; Morse GD
    J Am Geriatr Soc; 1993 Aug; 41(8):808-10. PubMed ID: 8340557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of protein binding on drug penetration into blister fluid.
    Shyu WC; Quintiliani R; Nightingale CH; Dudley MN
    Antimicrob Agents Chemother; 1988 Jan; 32(1):128-30. PubMed ID: 3162360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
    Brendel E; Zschunke M; Meineke I
    J Chromatogr; 1985 May; 339(2):359-65. PubMed ID: 4008574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefonicid concentrations in human aqueous humor.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1984 Mar; 102(3):433-4. PubMed ID: 6608343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal transport of cefonicid.
    Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
    Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT; Conte JE
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
    Dudley MN; Nightingale CH; Drezner AD; Low HB; Quintiliani R
    Antimicrob Agents Chemother; 1984 Sep; 26(3):347-50. PubMed ID: 6334490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW; McCormack GD; Goodman JS
    Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy.
    Maki DG; Lammers JL; Aughey DR
    Rev Infect Dis; 1984; 6 Suppl 4():S887-95. PubMed ID: 6395279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and myocardial levels of cefonicid during open-heart surgery.
    Sterling RP; Connor DJ; Norman JC
    J Natl Med Assoc; 1983 Nov; 75(11):1075-80. PubMed ID: 6655710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.